The FDA is continuing to crack down on misleading ads for drugs as pharmaceutical companies become more aggressive and creative with their marketing tactics. The agency issued 45 warning letters in the first eight months of the year for marketing violations, compared with 21 in all of 2008.

Full Story:

Related Summaries